Dolby Laboratories (NYSE:DLB) Releases Q2 2025 Earnings Guidance

Dolby Laboratories (NYSE:DLB) issued an update on its second quarter 2025 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 1.190-1.340 for the period, compared to the consensus earnings per share estimate of 1.350. The company issued revenue guidance of $355.0 million-$385.0 million, compared to the consensus revenue estimate of $387.2 million. Dolby Laboratories also updated its FY 2025 guidance to 3.990-4.140 EPS.

Dolby Laboratories Stock Up 8.8 %

DLB traded up $7.10 during trading on Thursday, reaching $87.73. 180,088 shares of the company were exchanged, compared to its average volume of 435,043. The company has a market cap of $8.37 billion, a price-to-earnings ratio of 32.34 and a beta of 0.98. Dolby Laboratories has a 12-month low of $66.35 and a 12-month high of $88.11. The company’s 50-day moving average is $79.15 and its two-hundred day moving average is $75.65.

Dolby Laboratories Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 10th. Stockholders of record on Tuesday, December 3rd were given a $0.33 dividend. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.30. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.50%. The ex-dividend date of this dividend was Tuesday, December 3rd. Dolby Laboratories’s dividend payout ratio (DPR) is 48.71%.

Analyst Ratings Changes

DLB has been the topic of several recent analyst reports. Barrington Research reiterated an “outperform” rating and issued a $100.00 target price on shares of Dolby Laboratories in a research note on Monday. StockNews.com raised Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, December 4th. Finally, Rosenblatt Securities restated a “buy” rating and issued a $100.00 target price on shares of Dolby Laboratories in a research note on Thursday.

Insider Buying and Selling at Dolby Laboratories

In related news, Director Peter C. Gotcher sold 6,079 shares of the firm’s stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $78.96, for a total transaction of $479,997.84. Following the transaction, the director now directly owns 37,593 shares of the company’s stock, valued at approximately $2,968,343.28. This trade represents a 13.92 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP John D. Couling sold 50,000 shares of the company’s stock in a transaction that occurred on Friday, November 22nd. The stock was sold at an average price of $80.04, for a total value of $4,002,000.00. Following the completion of the sale, the senior vice president now directly owns 106,806 shares of the company’s stock, valued at approximately $8,548,752.24. This represents a 31.89 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 135,917 shares of company stock worth $10,877,739 over the last three months. 38.39% of the stock is owned by insiders.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.